Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | PRKCI | P41743 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7014615 | 0.71 | SLC2A1 (0.32) | SLC2A1ALDH1A1PARP1PRKCIPDE4B | |
| SCHEMBL8541187 | 0.71 | SLC2A1 (0.32) | SLC2A1ALDH1A1PARP1PRKCIPDE4B | |
| SCHEMBL9236847 | 0.57 | SLC2A1 (0.32) | SLC2A1ALDH1A1PARP1PRKCIPDE4B | |
| SCHEMBL16416075 | 0.54 | SLC2A1 (0.36) | SLC2A1ALDH1A1PARP1PRKCIPDE4B | |
| SCHEMBL1562626 | 0.54 | — | — | |
| SCHEMBL2119154 | 0.53 | CYP11B1 (0.35) | — | |
| SCHEMBL4564464 | 0.52 | HSD17B10 (0.50) | SLC2A1ALDH1A1PARP1PRKCIPDE4B | |
| SCHEMBL6312891 | 0.51 | — | — | |
| SCHEMBL12118183 | 0.51 | — | — | |
| SCHEMBL7013361 | 0.51 | ALDH1A1 (0.48) | SLC2A1ALDH1A1PARP1PRKCIPDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5719155-A | CARDIOVASCULAR DISORDERS | JAPAN TOBACCO INC. (JP) | 1998-02-17 | — | — | US | disclosed |
| EP-0677519-A1 | CHROMAN DERIVATIVE AND MEDICINAL USE THEREOF | Japan Tobacco Inc. (JP) | 1995-10-18 | — | — | EP | disclosed |